跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vilglad - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vilglad
Approved
STANDARD
Vilglad
Hetero Labs Limited (Unit V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
18b4217c1754e8e7
Company
Hetero Labs Limited (Unit V)
Type
Standard
Approval Details
Approval Id
18b4217c1754e8e7
Drug Approval Philippines Name
Vilglad
Product Name
Vilglad
Registration Number
DRP-15894
Brand Name
Vilglad
Generic Name
Vildagliptin
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Hetero Labs Limited (Unit V)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
26 September 2024
Expiry Date
26 September 2029
Pharmacologic Category
Dipeptidyl peptidase 4 (DPP-4) inhibitors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
18b4217c1754e8e7
Type
Standard
Back to Philippines FDA Approvals